Literature DB >> 19584679

Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model.

Yaming Wei1, Yuqiang Nie, Jieying Lai, Yu-Jui Yvonne Wan, Yuyuan Li.   

Abstract

OBJECTIVE: This study compares the population and repair ability of bone marrow hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) in experimental colitis (EC) rat model after allogeneic stem-cell transplantation (SCT).
METHODS: EC was induced by 2, 4, 6-trinitrobenzenesulfonic acid (TNBS). The HSCs, MSCs, HSCs+MSCs, derived from male Sprague-Dawley rats, were cultured and labeled with bromodeoxyuridine and then transplanted into the EC rat. The colon samples were collected for histologic evaluation at days 7, 14, and 21 posttransplantation. Immunohistochemical staining, polymerase chain reaction, and fluorescence in situ hybridization were used to detect donor stem cells population.
RESULTS: EC induced by TNBS had characteristics similar to those of Crohn's disease. A large number of bromodeoxyuridine- labeled HSCs or MSCs were detected on days 7, 14, and 21 posttransplantation. Sex-determining region of Y chromosomes (sry) was found in all EC regions, but not in control and normal tissues. A clear localization of Y chromosomes in the colons of EC rat was detected by fluorescence in situ hybridization. Immunohistochemical staining revealed that HSCs or MSCs had similar population ability. When HSCs and MSCs were combined, gross morphologic scores significantly improved 21 days post-SCT compared with the control without SCT, but only slightly better than that of HSCs or MSCs alone.
CONCLUSIONS: Allogeneic transplantation of HSCs or MSCs alone could populate in the injured regions of the colons, both showed similar population ability in the colons of the TNBS-induced EC model rats. Combination transplantation of HSCs with MSCs could improve the gross morphologic scores of EC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584679      PMCID: PMC3991233          DOI: 10.1097/TP.0b013e3181a9f0a7

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

Review 1.  Stem cell transplantation for inflammatory bowel disease: practical and ethical issues.

Authors:  C J Hawkey; J A Snowden; A Lobo; C Beglinger; A Tyndall
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

3.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

4.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

5.  Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial.

Authors:  W J Sandborn; W J Tremaine; K P Offord; G M Lawson; B T Petersen; K P Batts; I T Croghan; L C Dale; D R Schroeder; R D Hurt
Journal:  Ann Intern Med       Date:  1997-03-01       Impact factor: 25.391

6.  Course of Crohn's disease after allogeneic marrow transplantation.

Authors:  S O Lopez-Cubero; K M Sullivan; G B McDonald
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

7.  Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation.

Authors:  Markus Ditschkowski; Hermann Einsele; Rainer Schwerdtfeger; Donald Bunjes; Rudolf Trenschel; Dietrich W Beelen; Ahmet H Elmaagacli
Journal:  Transplantation       Date:  2003-05-27       Impact factor: 4.939

Review 8.  Molecular and clinical basis for the regeneration of human gastrointestinal epithelia.

Authors:  Ryuichi Okamoto; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2004-01       Impact factor: 7.527

9.  Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats.

Authors:  Yujiro Hayashi; Shingo Tsuji; Masahiko Tsujii; Tsutomu Nishida; Shuji Ishii; Hideki Iijima; Toru Nakamura; Hiroshi Eguchi; Eiji Miyoshi; Norio Hayashi; Sunao Kawano
Journal:  J Pharmacol Exp Ther       Date:  2008-04-30       Impact factor: 4.030

10.  Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract.

Authors:  Ryuichi Okamoto; Tomoharu Yajima; Motomi Yamazaki; Takanori Kanai; Makio Mukai; Shinichiro Okamoto; Yasuo Ikeda; Toshifumi Hibi; Johji Inazawa; Mamoru Watanabe
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

View more
  16 in total

Review 1.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

Review 2.  Intestinal stem cells and their roles during mucosal injury and repair.

Authors:  Matthew D Neal; Ward M Richardson; Chhinder P Sodhi; Anthony Russo; David J Hackam
Journal:  J Surg Res       Date:  2010-05-21       Impact factor: 2.192

Review 3.  Autologous bone marrow stem cell transplantation for the treatment of ulcerative colitis complicated with herpes zoster: a case report.

Authors:  Hang Xiang; Xiaomei Zhang; Chao Yang; Wenhuan Xu; Xin Ge; Rong Zhang; Ya Qiu; Wanjun Sun; Fan Li; Tianyuan Xiang; Haixu Chen; Zheng Wang; Qiang Zeng
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

4.  The possible role of mesenchymal stem cells therapy in the repair of experimentally induced colitis in male albino rats.

Authors:  Sohair Ahmed Fawzy; Rahma Kamal El-Din Abo-Elnou; Dalia Fathy Abd-El-Maksoud El-Deeb; Marwa Mohamed Yousry Abd-Elkader
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

Review 5.  Physiological and pathological role of local and immigrating colonic stem cells.

Authors:  Ferenc Sipos; Gábor Valcz; Béla Molnár
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

6.  Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat.

Authors:  Hiroki Tanaka; Yoshiaki Arimura; Takashi Yabana; Akira Goto; Masayo Hosokawa; Kanna Nagaishi; Kentaro Yamashita; Hiroyuki Yamamoto; Yasushi Sasaki; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2010-09-17       Impact factor: 7.527

Review 7.  The role of the bone marrow derived mesenchymal stem cells in colonic epithelial regeneration.

Authors:  Gábor Valcz; Tibor Krenács; Ferenc Sipos; Katalin Leiszter; Kinga Tóth; Zsófia Balogh; Annamária Csizmadia; Györgyi Muzes; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2010-04-21       Impact factor: 3.201

8.  Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors.

Authors:  Shuhei Watanabe; Yoshiaki Arimura; Kanna Nagaishi; Hiroyuki Isshiki; Kei Onodera; Masanao Nasuno; Kentaro Yamashita; Masashi Idogawa; Yasuyoshi Naishiro; Masaki Murata; Yasushi Adachi; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-11-12       Impact factor: 7.527

9.  Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts.

Authors:  Petra A B Klemmt; Vida Vafaizadeh; Bernd Groner
Journal:  Stem Cell Res Ther       Date:  2010-07-07       Impact factor: 6.832

10.  Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis.

Authors:  E Legaki; M G Roubelakis; G E Theodoropoulos; A Lazaris; A Kollia; G Karamanolis; E Marinos; M Gazouli
Journal:  Stem Cell Rev Rep       Date:  2016-10       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.